MedPath

Needle-X: Usability Testing of a Smartphone Application

Not Applicable
Withdrawn
Conditions
Opioid Dependence
Interventions
Behavioral: Smartphone Application
Registration Number
NCT03665298
Lead Sponsor
NYU Langone Health
Brief Summary

Mobile health interventions offer a longitudinal approach to reducing the burden of substance use disorders and may stem the rise of the opioid overdose epidemic. Smartphone applications are one of the most popular mobile phone features nationally, among patients in addiction treatment, and among criminal justice involved (CJI) patients enrolled in addiction treatment. This research conducted at Bellevue Hospital's inpatient detoxification program established attitudes and self-reported behaviors favorable to theoretical smartphone applications addressing opioid use, HIV, and HCV prevention and management strategies. This study aims to assess the feasibility and usability of a smartphone application to enhance access to sterile needles, naloxone overdose kits, and addiction treatment programs in New York City.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Fluent in spoken and written English;
  • Meets or has previously met DSM-5 criteria for current opioid use disorder, of at least moderate severity;
  • Owns or has owned a smartphone
Read More
Exclusion Criteria
  • Any patient who does not meet the inclusion criteria as above, is clinically unstable per the unit admitting physicians, refuses to participate in the study, or is cognitively impaired.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Needle XSmartphone ApplicationSmartphone application application to enhance access to sterile needles, naloxone overdose kits, and addiction treatment programs in New York City.
Primary Outcome Measures
NameTimeMethod
Feasibility of Needle-X application12 Months

number of patients enrolled, as this study will include a single interaction, at which point the patient will no longer be part of the study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

New York University School of Medicine

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath